
Cardiac Biotech Solutions
(OTC) CBSC
Cardiac Biotech Solutions Financials at a Glance
Market Cap
$4.96M
Revenue (TTM)
$119.13K
Net Income (TTM)
$1.20M
EPS (TTM)
$-0.01
P/E Ratio
-2.83
Dividend
$0.00
Beta (Volatility)
-0.00 (Low)
Dividend
$0.00
Beta (Volatility)
-0.00 (Low)
Price
$0.03
Volume
29,733
Open
$0.03
Price
$0.03
Volume
29,733
Open
$0.03
Previous Close
$0.03
Daily Range
$0.03 - $0.03
52-Week Range
$0.02 - $0.06
Dividend
$0.00
Beta (Volatility)
-0.00 (Low)
Price
$0.03
Volume
29,733
Open
$0.03
Previous Close
$0.03
Daily Range
$0.03 - $0.03
52-Week Range
$0.02 - $0.06
CBSC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cardiac Biotech Solutions
Industry
Pharmaceuticals
Sector
Health CareCEO
Charles Martin
Website
www.cbscientificinc.comHeadquarters
Las Vegas, CA 92029, US
CBSC Financials
Key Financial Metrics (TTM)
Gross Margin
38%
Operating Margin
-11%
Net Income Margin
-10%
Return on Equity
0%
Return on Capital
84%
Return on Assets
-3%
Earnings Yield
-35.34%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.96M
Shares Outstanding
165.44M
Volume
29.73K
Avg. Volume
19.24K
Financials (TTM)
Gross Profit
$41.40K
Operating Income
$1.33M
EBITDA
$1.69M
Operating Cash Flow
$1.25M
Capital Expenditure
$0.00
Free Cash Flow
$1.25M
Cash & ST Invst.
$50.01K
Total Debt
$263.09K
Cardiac Biotech Solutions Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$40.33K
+241.7%
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.96M
N/A
Market Cap/Employee
$992.64K
N/A
Employees
5
N/A
Net Income
$573.68K
+15.1%
EBITDA
$560.34K
-10.4%
Quarterly Fundamentals
Net Cash
$479.12K
-512.5%
Accounts Receivable
$88.37K
+888.9%
Inventory
$27.89K
+0.0%
Long Term Debt
$0.00
N/A
Short Term Debt
$485.00K
+156.0%
Return on Assets
-3.19%
N/A
Return on Invested Capital
84.07%
N/A
Free Cash Flow
$182.25K
-13.0%
Operating Cash Flow
$182.25K
-13.0%